Copyright © Inderes 2011 - present. All rights reserved.
Log ind for at modtage meddelelser.
  • Latest
  • Markeder
    • Aktieoversigt
    • Finanskalender
    • Dividends Calendar
    • Research
    • Artikler
  • InderesTV
  • Forum
  • Om os
    • Fulgte selskaber
    • Team

Elekta

51,85

 

SEK

 

+0,48 %

Mindre end 1K følgere

EKTA B

NASDAQ Stockholm

Medical Equipment & Services

Health Care

Overview
Ownership
Investor consensus
Sammenligne
+0,48%
+10,6%
-20,78%
-15,21%
-19,92%
-35,47%
-25,61%
-43,51%
+494,37%

Elekta operates in the medical technology industry and focuses on the development, manufacture and distribution of medical equipment for cancer treatment and neurosurgery. The company's products include radiotherapy machines and diagnostic imaging systems. The business has a global market position. Elekta was founded in 1972 and is headquartered in Stockholm.

Læs mere
Markedsværdi
19,89 mia. SEK
Aktieomsætning
45,44 mio. SEK
Omsætning
18,12 mia.
EBIT %
11,25 %
P/E
15,21
Udbytteafkast, %
4,63 %
Finanskalender
28.5
2025

Årsrapport '25

28.8
2025

Delårsrapport Q1'26

4.9
2025

Generalforsamling '25

Alle
Selskabsmeddelelser
ViserAlle indholdstyper
Pressemeddelelsefor 11 timer siden

Invitation to the presentation of Elekta’s fiscal year 2024/25

Elekta
Pressemeddelelse3.5.2025, 13.45

Clinical trial shows more precise radiotherapy using Elekta Unity MR-Linac preserves sexual function in men with prostate cancer

Elekta
Pressemeddelelse16.4.2025, 05.30

Invitation to Elekta's Investor Update event on June 10, 2025

Elekta

Join Inderes community

Don't miss out - create an account and get all the possible benefits

Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools
Create account
Pressemeddelelse3.4.2025, 05.30

Elekta and Azra AI announce partnership to enhance cancer registry operations with AI-powered automation

Elekta
Selskabsmeddelelse26.2.2025, 17.00

Gustaf Salford to leave position as President and CEO of Elekta as of March 6

Elekta
Selskabsmeddelelse21.2.2025, 06.30

Q3 Report, November–January 2024/25

Elekta
Pressemeddelelse21.2.2025, 06.29

Elekta secures major win with IMSS: Eight linacs to revolutionize cancer treatment in Mexico

Elekta
Pressemeddelelse21.2.2025, 06.28

Elekta Unity to become cornerstone of Moffitt Cancer Center’s MRgRT program

Elekta
Pressemeddelelse7.2.2025, 06.30

Invitation to the presentation of Elekta’s third quarter 2024/25

Elekta
Pressemeddelelse5.2.2025, 13.00

Elekta ONE OIS secures top spot in 2025 Best in KLAS: Software and Services Report

Elekta
Pressemeddelelse17.12.2024, 06.30

German cancer center treats first patient in the world with Elekta Evo CT-Linac

Elekta
Pressemeddelelse6.12.2024, 06.30

Invitation to Elekta's Deep Dive event on December 19

Elekta
Selskabsmeddelelse27.11.2024, 06.30

Q2 Report, August–October 2024/25

Elekta
Pressemeddelelse14.11.2024, 06.30

Invitation to the presentation of Elekta’s second quarter 2024/25

Elekta
Selskabsmeddelelse1.11.2024, 06.30

Caroline Leksell Cooke steps down from Elekta's Board of Directors

Elekta
Pressemeddelelse31.10.2024, 06.30

Elekta’s Nomination Committee for the Annual General Meeting 2025

Elekta
Pressemeddelelse1.10.2024, 11.30

First major advance in radiation treatment for high-grade gliomas in more than 25 years presented at ASTRO 2024

Elekta
Pressemeddelelse1.10.2024, 05.30

Elekta issues a SEK 1.5 billion bond and signs a revolving credit facility of SEK 1 billion

Elekta
Pressemeddelelse24.9.2024, 05.30

Elekta Evo submitted to U.S. FDA for premarket approval – to be featured at ASTRO

Elekta
Pressemeddelelse19.9.2024, 05.30

Caroline Leksell Cooke to lead Elekta Neuro Solutions

Elekta
Find us on social media
  • Inderes Forum
  • Youtube
  • Facebook
  • X (Twitter)
Tag kontakt
  • info@hcandersencapital.dk
  • Bredgade 23B, 2. sal
    1260 København K
Inderes
  • Om os
  • Our team
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Servicevilkår
  • Privatlivspolitik
  • Disclaimer
Inderes’ ansvarsfraskrivelse kan findes her. Detaljeret information om hver aktie, der aktivt overvåges af Inderes og HC Andersen Capital, er tilgængelig på de virksomhedsspecifikke sider på Inderes' hjemmeside. © Inderes Oyj. All rights reserved.